Takuma Narita

3.3k total citations
95 papers, 2.4k citations indexed

About

Takuma Narita is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Takuma Narita has authored 95 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 26 papers in Pulmonary and Respiratory Medicine and 25 papers in Nephrology. Recurrent topics in Takuma Narita's work include Chronic Kidney Disease and Diabetes (20 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Urinary and Genital Oncology Studies (12 papers). Takuma Narita is often cited by papers focused on Chronic Kidney Disease and Diabetes (20 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Urinary and Genital Oncology Studies (12 papers). Takuma Narita collaborates with scholars based in Japan, United States and Canada. Takuma Narita's co-authors include Hiroki Fujita, Tsukasa Morii, Seiki Ito, Masafumi Kakei, Mihoko Hosoba, Hiromi Fujishima, Yuichiro Yamada, Takashi Shimotomai, Takehiro Sato and Jun Koshimura and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takuma Narita

93 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuma Narita Japan 26 661 573 552 548 416 95 2.4k
Michele T. Rooney United States 10 722 1.1× 538 0.9× 317 0.6× 769 1.4× 248 0.6× 18 2.1k
Michal Herman‐Edelstein Israel 19 570 0.9× 1.1k 1.9× 621 1.1× 950 1.7× 315 0.8× 33 2.9k
Dong Cheol Han China 15 336 0.5× 587 1.0× 313 0.6× 801 1.5× 451 1.1× 33 2.3k
Thimoteus Speer Germany 27 374 0.6× 640 1.1× 534 1.0× 762 1.4× 222 0.5× 80 2.5k
Hideki Tahara Japan 28 1.0k 1.6× 466 0.8× 530 1.0× 1.1k 2.1× 356 0.9× 75 3.3k
Atsushi Fukatsu Japan 35 784 1.2× 1.3k 2.2× 760 1.4× 1.0k 1.9× 238 0.6× 102 4.0k
J. Egido Spain 25 487 0.7× 983 1.7× 458 0.8× 529 1.0× 256 0.6× 42 3.2k
Paul F. Williams Australia 29 502 0.8× 622 1.1× 603 1.1× 396 0.7× 282 0.7× 89 2.6k
Samy Hadjadj France 31 1.4k 2.2× 597 1.0× 668 1.2× 419 0.8× 301 0.7× 159 2.9k
Adam M. Smiles United States 28 840 1.3× 718 1.3× 547 1.0× 1.5k 2.7× 429 1.0× 33 3.2k

Countries citing papers authored by Takuma Narita

Since Specialization
Citations

This map shows the geographic impact of Takuma Narita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuma Narita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuma Narita more than expected).

Fields of papers citing papers by Takuma Narita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuma Narita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuma Narita. The network helps show where Takuma Narita may publish in the future.

Co-authorship network of co-authors of Takuma Narita

This figure shows the co-authorship network connecting the top 25 collaborators of Takuma Narita. A scholar is included among the top collaborators of Takuma Narita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuma Narita. Takuma Narita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Narita, Takuma, Yuki Tobisawa, Andrey A. Bobkov, et al.. (2023). TMEM2 is a bona fide hyaluronidase possessing intrinsic catalytic activity. Journal of Biological Chemistry. 299(9). 105120–105120. 14 indexed citations
4.
Hatakeyama, Shingo, Atsushi Imai, Mika Kumagai, et al.. (2020). A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project. Urologia Internationalis. 105(3-4). 232–239. 9 indexed citations
5.
Oikawa, M., Toshikazu Tanaka, Takuma Narita, et al.. (2020). Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy. Pathology & Oncology Research. 26(4). 2115–2121. 3 indexed citations
6.
Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2020). Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(8). 684.e17–684.e24. 9 indexed citations
8.
Hatakeyama, Shingo, Hayato Yamamoto, Yuki Tobisawa, et al.. (2017). Aortic calcification burden predicts deterioration of renal function after radical nephrectomy. BMC Urology. 17(1). 13–13. 6 indexed citations
9.
Narita, Takuma, Shingo Hatakeyama, Hayato Yamamoto, et al.. (2017). Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma. International Journal of Urology. 24(5). 361–366. 11 indexed citations
10.
Shimizu, Tatsunori, Takehiro Sato, Katsushi Tsukiyama, et al.. (2017). Food Intake Affects Sperm-Egg Fusion Through the GIP/PSG17 Axis in Mice. Endocrinology. 158(7). 2134–2144. 9 indexed citations
12.
Fujita, Hiroki, Tsukasa Morii, Hiromi Fujishima, et al.. (2013). The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney International. 85(3). 579–589. 273 indexed citations
13.
Hatakeyama, Shingo, Tohru Yoneyama, Itsuto Hamano, et al.. (2013). Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center. BMC Urology. 13(1). 47–47. 44 indexed citations
15.
Narita, Takuma, Mihoko Hosoba, Masafumi Kakei, & Seiki Ito. (2006). Increased Urinary Excretions of Immunoglobulin G, Ceruloplasmin, and Transferrin Predict Development of Microalbuminuria in Patients With Type 2 Diabetes. Diabetes Care. 29(1). 142–144. 66 indexed citations
16.
Fujita, Hiroki, Tsukasa Morii, Jun Koshimura, et al.. (2006). Possible Relationship between Adiponectin and Renal Tubular Injury in Diabetic Nephropathy. Endocrine Journal. 53(6). 745–752. 49 indexed citations
17.
Koshimura, Jun, Hiroki Fujita, Takuma Narita, et al.. (2004). Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochemical and Biophysical Research Communications. 316(1). 165–169. 99 indexed citations
19.
Fujita, Hiroki, Takuma Narita, Hiroyuki Meguro, et al.. (1999). Lack of Association Between the Heparan Sulfate Proteoglycan Gene Polymorphism and Diabetic Nephropathy in Japanese NIDDM with Proliferative Diabetic Retinopathy. Renal Failure. 21(6). 659–664. 1 indexed citations
20.
Narita, Takuma, Jun Koshimura, Katsunori Suzuki, et al.. (1999). Effects of Short-Term Glycemic Control, Low Protein Diet and Administration of Enalapril on Renal Hemodynamics and Protein Permselectivity in Type 2 Diabetic Patients with Microalbuminuria.. The Tohoku Journal of Experimental Medicine. 189(2). 117–133. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026